Table 4.
Anxiety, Quality of Life, and Medical Utilization among engaged Lantern participants. Significant findings after adjusting for diabetes and insurance type.
| Measures | Mean change (SD) | Effect size (Cohen d) | Mixed-effects model | ||||
| Within group (95% CI) | Between group (95% CI) | Beta | SEa | P value | |||
| Generalized Anxiety Disorder-7 (n=227) | |||||||
|
|
Active | –3.16 (5.38) | –0.59 (–0.93 to –0.24) | 0.22 (–0.07-0.50) | –1.20 | 0.81 | .14 |
|
|
Control | –1.96 (5.75) | –0.34 (–0.56 to –0.12) | ||||
| Short Form Health Survey Mental Composite Score (n=205) | |||||||
|
|
Active | 6.47 (11.22) | 0.58 (0.18 to 0.98) | 0.28 (–0.04-0.60) | 3.23 | 1.71 | .06 |
|
|
Control | 3.4 (10.77) | 0.32 (0.09 to 0.54) | ||||
| Short Form Health Survey Physical Composite Score (n=207) | |||||||
|
|
Active | 4.72 (9.4) | 0.50 (0.10 to 0.90) | 0.40 (0.08-0.72) | 3.79 | 1.46 | .01 |
|
|
Control | 0.95 (9.12) | 0.10 (–0.12 to 0.33) | ||||
| High utilizer at 6 months (yes/no) | —b | — | Odds ratio=0.04 | –3.20 | 0.69 | <.0001 | |
aSE: standard error.
bNot applicable.